Santen’s Low-Dose Atropine Gains UK Regulatory Clearance for Pediatric Myopia
A small dose, a big step. The UK gives Ryjunea the green light. The UK Medicines and Healthcare products Regulatory…
Sydnexis Receives FDA Complete Response Letter for SYD-101 Pediatric Myopia Treatment
It’s not the “yes” Sydnexis hoped for…but it’s not a “no,” either. The U.S. Food and Drug Administration (FDA) has…
latest posts
